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Abstract
The Ca2 binding sites of the Ca2-ATPase of skeletal muscle sarcoplasmic reticulum (SR) have been identified as two
high-affinity sites orientated towards the cytoplasm, two sites of low affinity facing the lumen, and a transient occluded
species that is isolated from both membrane surfaces. Binding and release studies, using 45Ca2, have invoked models with
sequential binding and release from high- and low-affinity sites in a channel-like structure. We have characterised turnover
conditions in isolated SR vesicles with oxalate in a Ca2-limited state, [Ca2]lim, where both high- and low-affinity sites are
vacant in the absence of chelators (Biochim. Biophys. Acta 1418 (1999) 48^60). Thapsigargin (TG), a high-affinity specific
inhibitor of the Ca2-ATPase, released a fraction of total Ca2 at [Ca2]lim that accumulated during active transport.
Maximal Ca2 release was at 2:1 TG/ATPase. Ionophore, A23187, and Triton X-100 released the rest of Ca2 resistant to
TG. The amount of Ca2 released depended on the incubation time at [Ca2]lim, being 3.0 nmol/mg at 20 s and 0.42 nmol/mg
at 1000 s. Rate constants for release declined from 0.13 to 0.03 s31. The rapidly released early fraction declined with time and
k = 0.13 min31. Release was not due to reversal of the pump cycle since ADP had no effect; neither was release impaired with
substrates acetyl phosphate or GTP. A phase of reuptake of Ca2 followed release, being greater with shorter delay (up to
200 s) following active transport. Reuptake was minimal with GTP, with delays more than 300 s, and was abolished by
vanadate and at higher [TG], s 5 WM. Ruthenium red had no effect on efflux, indicating that ryanodine-sensitive efflux
channels in terminal cisternal membranes are not involved in the Ca2 release mechanism. It is concluded that the Ca2
released by TG is from the occluded Ca2 fraction. The Ca2 occlusion sites appear to be independent of both high-affinity
cytoplasmic and low-affinity lumenal sites, supporting a multisite ‘in line’ sequential binding mechanism for Ca2
transport. ß 2000 Elsevier Science B.V. All rights reserved.
Keywords: Sarcoplasmic reticulum; Ca2 transport; Ca2-ATPase; Thapsigargin; Ca2 occlusion; Channel
0005-2736 / 00 / $ ^ see front matter ß 2000 Elsevier Science B.V. All rights reserved.
PII: S 0 0 0 5 - 2 7 3 6 ( 0 0 ) 0 0 2 8 0 - 7
Abbreviations: AcP, acetyl phosphate; [Ca2]lim, limiting concentration of medium or cytosolic free calcium ions; DMSO, dimethyl-
sulfoxide; EGTA, ethylene glycol bis(L-amino ethyl ether)-N,N,NP,NPtetraacetic acid; E-P, phosphorylated forms of the Ca2-ATPase;
E1-P, forms with high-a⁄nity cytosolic-orientated Ca2 binding sites; E2-P, forms with low-a⁄nity inward-orientated Ca2 binding sites;
E2-PGCa2f, phosphoenzyme with occluded Ca2 ; EA2 .TG, non-phosphorylatable stable isomer of E2.TG; Fmin and Fmax, £uorescence of
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1. Introduction
The P-type cation pumps include the plasma mem-
brane Na,K-ATPase, Ca2-ATPase of sarco- and
endoplasmic reticulum (SERCA), the plasma mem-
brane Ca2-ATPase and gastric H,K-ATPase. All
of these systems share a remarkable number of char-
acteristics, including topographical features, con-
served residues, phosphoenzyme intermediate species
(EP), catalytic cycles, and presumably also similar
energy transduction mechanisms (for review, see
[1]). Primary transported cations, Na, Ca2, and
H bind with high a⁄nity to the E1 species, and
become occluded before transition to the low-a⁄nity
E2 conformation, prior to their release to the trans
membrane surface. There is general agreement as to
the functional properties of these three states, how-
ever it is still uncertain whether the sites represent
transient alternate conformations of the pump pro-
tein, or whether they exist permanently, and that
transported cations migrate sequentially from one
site to another [2].
Two Ca2 ions bind with high a⁄nity and positive
cooperativity to cytoplasmic oriented sites on E1 [3].
Binding of the ¢rst Ca2 (site I) augments binding to
the second site (site II), which in turn ‘locks’ the ¢rst
deeper site, such that it is relatively stable in EGTA
or to displacement of 45Ca2-labelled in the ¢rst site
by 40Ca2 in the medium [4,5]. These ¢ndings lead to
a model in which E1.2Ca2 binding sites are located
in a shallow well or channel-like structure [6]. Prop-
erties of E2-type low-a⁄nity lumenally orientated
binding sites are less certain. Initially it was reported
that these low-a⁄nity sites did not show ¢rst-in ¢rst-
out behaviour. There is now convincing evidence for
four Ca2 binding sites [7^11]. Failure to observe
¢rst-in ¢rst-out behaviour has been explained by
scrambling during the occluded state [12].
Site-directed mutagenesis has provided under-
standing as to the nature of the Ca2 ligands on
putative membrane helices, M4, M5, M6 and M8
(see [2] for review). These include Glu309 in M4,
Glu771 in M5, Asn796, Thr799, and Asn800 in M6,
and Glu908 in M8. Mutations to Glu309 and Asn796
appear to decrease binding to site II, whilst mutants
E771Q, T799A and E908A are involved in Ca2
binding to site I. Ligands between M4 and M6
may be assigned to site II, while those between M5
and M6 can be assigned to site I. In order to account
for ligand assignment that cannot be explained by
the in-line stacking model, MacLennan et al. have
proposed a ‘side-by-side’ structure in which the path-
way of Ca2 translocation would be angular, rather
than more direct [13].
The sesquiterpene, thapsigargin (TG), is a speci¢c
and potent inhibitor of sarco- and endoplasmic retic-
ulum Ca-ATPases (SERCA), and is used to increase
cytosolic [Ca2] in a wide range of tissues [14^16].
Although TG binds to E1 and E2, it favours E2, and
is competitive with Ca2 because it promotes the
reaction E2.TGCEA2 .TG, a stable form of E2 that
cannot be phosphorylated by Pi [17]. Since TG in-
hibits Ca2 uptake into intracellular stores, it is gen-
erally believed that the mechanism by which it in-
creases cytoplasmic [Ca2] is to allow continued
leakage that is not balanced by active uptake in a
pump/leak system [18^21].
In recent studies in our laboratory, we have char-
acterised the properties of the Ca2-ATPase when
both high- and low-a⁄nity Ca2 binding sites are
unoccupied as a result of transport into SR vesicles
in the presence of oxalate [22]. Since no high-a⁄nity
chelators are used to limit medium [Ca2]free, small
changes in calcium release or uptake can be moni-
tored by a Ca2 £uorophore, Fluo-3. We now report
on the TG-induced release of Ca2 from sites on the
Ca2-ATPase under conditions in which both high
(E1) and low (E2) a⁄nity Ca2 binding sites are va-
cant. Demonstration of Ca2 occlusion sites, inde-
pendent from cytoplasmic and lumenally oriented




The sources of materials were as follows: ATP,
Sigma; amylase, Boehringer Mannheim; Fluo-3,
pentammonium salt, Molecular Probes (Eugene,
OR); thapsigargin, lot 12841453, was obtained
from Sigma. Stock solutions, 1.0 mM, were prepared
in DMSO and kept at 310‡C. Standardised 100 mM
CaCl2 solution was prepared from Analar CaCO3,
adjusted to pH 5.6 with 1 M HCl.
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2.2. Preparation of skeletal muscle sarcoplasmic
reticulum vesicles
Isolated sarcoplasmic reticulum vesicles were pre-
pared from the back and hind leg muscle of white
rabbits by the method of Champeil et al. [23]. Amy-
lase, 1 mg, was added to the initial 460 g homogenate
in order to decrease glycogen content and phosphor-
ylase contamination to less than 5%, as determined
by polyacrylamide gel electrophoresis in sodium do-
decyl sulfate [24]. Protein concentrations were deter-
mined from the optical absorbance at 280 nm in
50 mM sodium phosphate, pH 7.0, 1% (w/v) sodium
dodecyl sulfate [23]. Suspensions of SR vesicles, 35^
40 mg/ml, were stored at 370‡C.
2.3. Measurement of maximum Ca2+ transport by
SR vesicles
The maximum rates of Ca2 transport were deter-
mined by the Fluo-3 method. SR vesicles, 0.25 mg/
ml, were incubated under standardised conditions
with 5 mM oxalate at 25‡C, and 20 WM CaCl2.
ATP, 2 mM, was added and £uorescence was re-
corded. At 200 s a single pulse of either 20 or
100 WM Ca2 was added to the cuvette and the
time taken for £uorescence to reach (Fmax3Fmin)/2,
the peak width at half height, was recorded. This was
assumed to be the time for the pulsed addition of
Ca2 to be transported into vesicles and to be stored
as calcium oxalate. It was also assumed that for 95%
of the timed period, the Ca2 pump was operating at
Vmax, since the K0:5 of Fluo-3 of 450 nM is equiva-
lent to the K0:5 of the Ca2 transport system [2].
Typical widths of a 100 WM peak of £uorescence
for uninhibited and 90% inhibited transport were
30 and 300 s, respectively.
2.4. Determination of steady state levels of
extravesicular [Ca2+], Ca2+ uptake and release
The kinetics of calcium uptake and release, and of
steady-state levels of extravesicular free [Ca2] were
monitored under standard conditions at 25‡C in
medium containing 20 mM MOPS/Tris, 20 mM his-
tidine (pH 6.8), 5 mM MgCl2, 5 mM sodium oxalate,
and 20 nM Fluo-3. SR vesicles, 0.25 mg/ml, were
used in all experiments reported here. Fluorescence
was recorded in a 1-cm cuvette with continuous mag-
netic stirring, using a SPEX Fluoromax spectro-
£uorimeter, with excitation at 509 nm, emission at
535 nm, and both slit widths of 1 mm. Free [Ca2],
in nM, was calculated assuming Kds for Ca2 bind-
ing of 450 nM at 25‡C [25], and of 864 nM at
37‡C [26], according to the equation [Ca2]free =
KdU(F3Fmin)/(Fmax3F), where F is the observed
£uorescence, and Fmax and Fmin are the £uorescence
with 20 WM Ca2 and 5 mM EGTA, respectively. A
linear relationship between temperature and Kd was
used to calculate free [Ca2] with inter- and extrap-
olation in temperature dependence studies in the
range 10^45‡C.
2.5. Simulation of catalytic intermediates under
steady-state conditions of the Ca2+-limited state
Steady-state intermediates were determined by nu-
merical integration of a 12-component unbranched
catalytic cycle of the Ca2-ATPase, using rate con-
stants given by Inesi and de Meis [27]. Simulation
was begun with ligand-free enzyme and continued
for 2 s in steps of 0.1 ms. Accuracy of the method
was checked by summing all intermediates, which
equaled that of total enzyme of 1.000 WM.
3. Results
3.1. Characterisation of SR vesicles at the
Ca2+-limited state
The kinetics of Ca2 uptake and release by SR
vesicles were studied, using the Ca2 £uorophore,
Fluo-3. The K0:5 for this probe, of 450 nM at
25‡C, is convenient since it matches the high-a⁄nity
Ca2-binding sites of the Ca2-ATPase, and its sen-
sitivity is such that 20 nM of the probe gives a stable
£uorescence signal with a good signal to noise ratio.
Inclusion of 20 mM histidine in the medium mini-
mises contribution of endogenous Zn2 to total £uo-
rescence [22]. Calculation of free [Ca2] was based
upon initial Fmax and of Fmin, following addition of
5 mM EGTA. Typically Fmin was 3^4% of Fmax. No
signi¢cant e¡ects of light scattering, due to formation
of intravesicular calcium oxalate crystals, were en-
countered. From the increase in light emission fol-
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lowing active loading of up to 20-fold extra Ca2 (2
Wmol/mg), it could be calculated that the expected
positive error from this source in a standard experi-
ment was equivalent to 0.2 nM free Ca2.
Active transport by SR vesicles, reduces medium
[Ca2]free to less than 0.1 WM in the presence of ox-
alate. A typical recording of £uorescence following
addition of ATP and pulsed additions of Ca2 is
shown in Fig. 1A, and its transform to [Ca2]free in
Fig. 1B. Ca2, 20 WM, was preincubated with SR to
promote ‘seeding’ of calcium oxalate, on initiating
Ca2 transport with ATP to obviate supersaturation.
The immediate sharp decrease in £uorescence signal
is due to chelation of Ca2 by ATP, since it occurred
following preincubation with TG (data not shown).
Limiting [Ca2], or [Ca2]lim, is typically in the range
45^54 nM [22]. The steady-state level of [Ca2]lim was
unchanged for up to 2 h at 25‡C, provided that ATP
concentrations were maintained above the 0.1 mM
level (data not shown). E¥ux of Ca2 followed sub-
strate depletion at rates of 0.02% of Vmax [22]. Intra-
vesicular [Ca2] in the presence of 5 mM oxalate has
been estimated to be approximately 10 WM [28].
3.2. E¡ects of inhibitors of active transport by
Ca2+-ATPase on release of Ca2+ from
SR vesicles at [Ca2+]lim
At the steady state of [Ca2]lim the sum of Ca2
release, by means of several di¡erent e¥ux pathways,
will equal active transport. Inhibitors of active trans-
port by SR vesicles, had varying e¡ects (Fig. 2A).
Addition of vanadate was followed by a stable
[Ca2]lim for up to 10 min. This would suggest that
active transport is minimal at the steady state. The
possibility that intravesicular Ca2 could be precipi-
tated as the Ca2^VO334 complex would not be ex-
pected to a¡ect interpretation of the data. The Ca2
ionophore, A23187, released a large fraction of the
Ca2 that had been loaded into SR vesicles as cal-
cium oxalate. The non-ionic detergent, Triton X-100,
solubilised SR membranes and released intravesicu-
lar Ca2 stores. Di¡erences in the emitted £uores-
cence signal between A23187 and Triton may be ex-
plained by the e¡ect of the detergent on light
scattering from vesicles. The e¡ects of A23187 and
Triton show that release of free Ca2 from calcium
oxalate precipitates within the SR lumen is not a
factor limiting e¥ux when Ca2 uptake is inhibited.
The e¡ects of thapsigargin (TG), a speci¢c inhib-
itor of the Ca2-ATPase, were unexpected. Addition
of 5 WM TG to 1 WM ATPase caused a slow release
of Ca2 from intact vesicles (t0:5 = 150 s), which
amount was less than that with ionophore or deter-
gent. It appears that TG released Ca2 from a pool
that is di¡erent from the bulk of Ca2, stored in the
form of calcium oxalate. This is clearly shown in Fig.
2B, where A23187 was able to release Ca2, in addi-
tion to that released by TG. Vanadate had little ef-
fect on the amount of Ca2 released by TG (Fig.
2C). It did, however, superimpose a small linear ef-
£ux, in excess of that from TG alone.
Fig. 1. Ca2 uptake by SR vesicles and the Ca2-limited state.
SR vesicles, 0.25 mg/ml, were incubated in standard medium
containing 20 WM Ca2 and 5 mM oxalate. ATP, 2 mM, was
added at 20 s, following which pulses of 20 and 100 WM Ca2
were added. Following incubation at 25‡C for 1 h, additions of
Ca2 were repeated. The £uorescence trace of Fluo-3 is shown
in A, and its transform to [Ca2]free, according to the technique
described in Section 2, is shown in B.
BBAMEM 77940 4-12-00
M.C. Berman / Biochimica et Biophysica Acta 1509 (2000) 42^54 45
3.3. Stoichiometry of thapsigargin^Ca2+-ATPase
interaction for Ca2+ release
Thapsigargin binds to the Ca2-ATPase, with a Kd
of less than 1039 M [29,30]. The [TG]-dependence of
the maximum amount of Ca2 released was shown to
be non-linear (Fig. 3A). In the presence of 1 WM
Ca2-ATPase (0.25 mg/ml), TG caused little e¡ect
below a 1:1 ratio. This then increased up to 2:1 ratio
and reached a plateau at higher TG concentrations.
In the range 1^5 WM TG the initial e¥ux reached a
maximum and then appeared to undergo reuptake.
The reuptake phase was inhibited in the 2^10 WM
TG range. TG inhibition of transport showed a dif-
ferent stoichiometry (Fig. 3B). Inhibition was linear
and maximal at 0.5:1 TG/ATPase. There are several
uncertainties in establishing molar ratios of TG/
Ca2-ATPase. The concentration of stock solutions
Fig. 2. E¡ect of TG and inhibitors of net Ca2 transport by SR vesicles. In A, SR vesicles were incubated in standard medium, as de-
scribed in Fig. 1. TG, 5 WM, vanadate, 1 mM, A23187, 2% (w/w), or Triton X-100, 1% (w/w), were added at 200 s. In B TG, 5 WM,
was added at 200 s, and A23187, 2% (w/w), at 600 s. The e¡ect of preincubation with 1 mM VO334 added at 200 s, followed by 5 WM
TG at 230 s, is shown in C.
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of TG rely on Suppliers’ data, and the compound is
presumed to be stable during storage at 4‡C. Of
more concern are measurements of the enzyme itself.
Maximum E-P levels of phosphorylation from 32Pi
are approx. 4.0 nmol/mg, which indicates that at
least 50% of the SR preparation may be inactive.
3.4. Quantitation of Ca2+ released by thapsigargin
Determination of the amount of Ca2 released
into the medium by TG is dependent upon the
change in [Ca2]free, monitored by Fluo-3, and the
bu¡ering capacity of the medium for Ca2. Bu¡ering
was determined by addition of known aliquots of
Ca2 to the medium, once [Ca2]free had reached its
maximum, following addition of TG (Fig. 4, inset).
Ca2 bu¡ering, de¢ned as the amount of added Ca2
required to cause an equimolar increase in medium
[Ca2]free, was 2.62 in medium containing 5 mM ox-
alate, and 2.80 in 10 mM phosphate bu¡er (Fig. 4).
In this experiment the maximum amount of Ca2
release increased medium [Ca2]free by 375 nM,
which allowing for Ca2 bu¡ering represents release
of 3.9 nmol/mg or 0.98 mol/mol Ca2-ATPase.
Fig. 3. E¡ects of varying TG on Ca2 release, reuptake and on Ca2 transport. In A, SR vesicles, 0.25 mg/ml, were preincubated in
standard medium with 20 WM Ca2 added. ATP, 2 mM, was added at t = 0 s, and varying [TG], in WM alongside each curve. The
amount of Ca2 released was estimated from a biexponential ¢t to correct for the reuptake phase, and is shown in B. Inhibition of
Ca2 transport by TG was determined in separate experiments following preincubation for 1 min at varying amounts of TG. Trans-
port was initiated with 2 mM ATP and determined from the pulse width at half height of a peak of Ca2, 100 WM, added at 200 s.
Data are plotted in B.
Fig. 4. Bu¡ering of released Ca2 by oxalate and phosphate.
Under standard conditions with either 5 mM or 10 mM phos-
phate, ATP, 2 mM was added at 0 s, and TG, 5 WM, at 150 s.
When the signal was steady at 400 s, CaCl2 was added in 0.25-
WM increments to a total of 1.75 WM (see inset). Bu¡ering ca-
pacity for Ca2 was calculated from the initial slope of a bino-
mial ¢t of the data. Bu¡ering capacity was 2.62 and 2.80 for
oxalate and phosphate, respectively.
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3.5. Variation in magnitude and kinetics of
TG-releasable Ca2+ with interval following active
transport
Preliminary experiments indicated that the charac-
teristics of the TG-releasable Ca2 fraction were de-
pendent on the delay between activation of Ca2
uptake by ATP and addition of TG. As expected,
molar excess of TG added to the reaction medium
prior to addition of ATP completely abolished the
Ca2 uptake phase. A series of experiments with in-
creasing delay period from 20 to 1000 s is shown in
Fig. 5A. TG, added 300^1000 s after the period of
active transport, whilst in the steady state of
[Ca2]lim, showed a single monotonic phase of re-
lease, with rate constant kw0.01 s31. For intermedi-
ate intervals, the kinetics of release were more com-
plex, in that a relatively rapid phase of release caused
an ‘overshoot’, following which there appeared to be
a phase of reuptake or binding of Ca2 to the SR.
The ¢nal steady-state [Ca2]free for delay periods be-
tween 20 and 1000 s was in the range 250^300 nM.
The amplitude of the initial rapid rate of Ca2 re-
lease, shown in Fig. 5B, was 3.0 nmol/mg, declining
to 0.9 nmol/mg at 1000 s. The rate constant for this
decline of the rapid phase was 0.13 min31. Concom-
itantly the rate constant for release declined from an
initial 0.11 s31 at 20 s delay to approximately 0.0075
s31 at 1000 s. The rate constant for decline in the
rapidly e¥uxed Ca2 at minimal delay times was 2.3
min31.
3.6. E¡ects of loading with alternate substrates
Acetyl phosphate (AcP) and GTP support Ca2
uptake into SR vesicles, but there is no possibility
of a fully reversible pump cycle. Fig. 6A shows
that release of Ca2 by TG is slower but greater
with vesicles that are loaded in the presence of AcP
or GTP. However, the release phase is modi¢ed in
vesicles that are actively loaded by GTP (Fig. 6B).
Here release is slower and there is no reuptake phase
as seen with ATP (cf. Fig. 5A). Di¡erences in the
kinetics of e¥ux and reuptake phases between ATP
and alternate substrates may be relevant for the
mechanism of reuptake (see Section 4).
Fig. 5. E¡ects of a delay between onset of transport and addition of TG. In A, under standard conditions, ATP was added at 10 s,
and 5 WM TG at varying intervals up to 1000 s. The amount of Ca2 released by TG was determined from a biexponential ¢t of the
curves up to 300 s delay. Longer delay curves were ¢tted to a single exponential. The data for Ca2 release (¢lled circles) and rate
constants, k1 (open circles) shown in B, which include results of several additional experiments, were ¢tted to a single exponential de-
cay. The best ¢t of Ca2 released (solid line) had an amplitude of 3.04 nmol/mg ATPase, and decay constant, k, of 0.13 min31. The
¢rst-order rate constants for Ca2 release versus delay were also ¢tted to a single exponential decay curve (dashed line)..
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3.7. ADP-sensitivity of thapsigargin-induced
Ca2+ release
Speci¢c release of Ca2 by TG indicates that its
mechanism of action must involve its interaction
with the Ca2-ATPase. In that case release of a frac-
tion of total Ca2 taken up into SR vesicles may be
explained by reversal of a single pump cycle with
release of Ca2. Reversal of the cycle would include
binding of ADP. ADP is expected to be present in
the medium under the usual experimental conditions,
assuming 10% hydrolysis of substrate, which would
release 200 WM ADP. Addition of phosphoenol py-
ruvate and pyruvate kinase, which should convert all
ADP present to ATP, had no e¡ect on the extent of
TG-released Ca2. Likewise addition of ADP, up to
1 mM, did not facilitate Ca2 release (data not
shown).
3.8. Variable loading of SR vesicles with Ca-oxalate
and its e¡ect on Ca2+ release
It is possible that during active transport lumenal
[Ca2]free increases above 10 WM, the expected equi-
librium value. In that case, Ca2 release would be
expected to vary with the degree of loading of SR
vesicles if TG-induced Ca2 release was through a
release channel, or by passive £ow of Ca2 through
an ionophoric pathway. In a series of experiments
Ca2 loading was varied from 0 to 2000 nmol/mg
SR and e¡ects of 5 WM TG measured at 300 s delay.
Active loading of up to 800 nmol/mg had no e¡ect
on the amount of Ca2 released by TG, which was
3.4 þ 0.23 nmol/mg and 1.7% of the amount of Ca2
actively transported. With 2000 nmol/mg of Ca2,
[Ca2]lim was elevated and virtually all of the Ca2
loaded was released by TG. Since most assays of
release were with 80 nmol/mg Ca2 it follows that
altered loading capacity did not in£uence the
amounts of Ca2 released by TG.
The speci¢c inhibitor of the Ca2 release channel,
Ruthenium red, 2 WM, had no e¡ect on Ca2 release
(data not shown), indicating that the physiological
ryanodine-sensitive release channel does not contrib-
ute to TG-induced release.
4. Discussion
Isolated sarcoplasmic reticulum (SR) vesicles, pre-
pared from rabbit skeletal muscle, provides near
ideal conditions for studies on active transport in
P-type cation pumps. Vesicles are well sealed and
the Ca2-ATPase pump protein is approximately
Fig. 6. E¡ects of pseudosubstrates on TG-induced Ca2 release. ATP, 2 mM, GTP, 2 mM, and AcP, 10 mM, were added to SR
vesicles, as before, and TG, 5 WM, at 300 s and [Ca2]free monitored in A. E¡ects of varying delay between onset of transport with
2 mM GTP and addition of 5 WM TG are shown in B.
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85% pure. Pump units are physiologically orientated,
with external ATP-binding sites representing the in
vivo situation, where out is synonymous with the
cytosolic surface [1]. Active transport has been
studied both by means of chelatometric dyes, either
by absorbance or £uorescence, or by measurements
of £uxes of 45Ca2 into or out of vesicles following
¢ltration to separate vesicles from medium. Such
studies are generally performed in the presence of
Ca2 chelators, either the reporting dyes themselves,
or with CaEGTA bu¡ers to control free [Ca2] in the
submicromolar range, which is relevant for physio-
logical studies. It is also in the range where activation
of many Ca2-dependent signalling events occur. A
feature of the present study is that it depends on
sequestration of contaminating medium Ca2 into
isolated SR vesicles to deplete medium Ca2 in the
absence of Ca2 bu¡ers.
Calcium uptake into SR vesicles in the presence of
oxalate or phosphate anions decreases medium free
Ca2 to a level of approximately 50 nM, following
which these levels are maintained for several hours at
25‡C. E¥ux pathways, which are minimal (0.02% of
Vmax), balance active uptake. This phenomenon has
been termed [Ca2]lim to indicate that the Ca2-ATP-
ase pump cycle is limited due to low medium (cyto-
solic) [Ca2]free [22]. Only a relatively small fraction
of total Ca2, stored as Ca2oxalate inside vesicles,
was released by TG. This is indicated in Fig. 2A,
where ionophore A23187, and the non-ionic deter-
gent, Triton X-100, caused rapid release of Ca2.
Ionophore also increased medium Ca2 once maxi-
mum e¡ects of TG had occurred (Fig. 2B). The ulti-
mate aim of this study was to establish the origins of
the TG-releasable Ca2 fraction.
The extent and kinetics of Ca2 release and reup-
take were dependent on a number of factors. [TG]
dependence of active transport was linear at lower
concentration, compatible with high-a⁄nity titration
of binding sites (Fig. 3B) [30]. There is, however, a
di¡erence in the apparent number of binding sites for
TG upon the ATPase. Inhibition of transport was
complete at 0.5 WM TG, whilst release was maximal
at 2.0 WM TG. The concentration of enzyme, 0.25
mg/ml, represents 1.0 WM pump units. According to
protein measurements, pure active enzyme should
contain 8 nmol/mg of phosphorylatable EP sites.
Measured maximum EP levels from Pi in the pres-
ence of EGTA are in the range 3.5^4.5 nmol/mg [31].
It has been suggested that 50% of Ca2ATPase pro-
tein is in the inactive form [32]. This readily explains
the 0.5:1.0 ratio of TG to enzyme sites titrated in the
transport inhibition experiments. The reason for the
2:1 titration of Ca2 release sites is not obvious. The
[TG]-dependence of Ca2 release is not linear in the
0^2.0 WM range. Little Ca2 is released up to 1.0 WM
TG, but release increases sharply between 1.0 and
2.0 WM of inhibitor. A possible explanation is that
in the lower range TG binds to both active and in-
active pump units. A stoichiometry of 2:1 does, how-
ever, imply that at least some of the pump units that
are inactive with regard to transport, nevertheless
can bind TG. Residual active pumps, e.g., at 1 WM
TG, may be capable of reuptake of Ca2 released
into the medium from TG-liganded enzyme.
Thapsigargin binds rapidly and tightly to the
Ca2-ATPase with Kd of 0.2 nM [33] to form a 1:1
complex. The inhibited enzyme shows decreased af-
¢nity and binding of Ca2 that has been explained by
preferential binding to the E2 conformation, with ir-
reversible formation of the dead-end complex,
EA2 :TG [34,35]. From these observations it was con-
cluded that the inhibitor does not bind to species
other than the unliganded E2. However, failure of
molar ratios of more than 1:1 for TG/E to further
decrease Ca2 a⁄nity, and e¡ects of the related in-
hibitor, thapsivillosum A, on the kinetics of quench-
ing of tryptophan, and their reversal by Ca2, lead
Wictome et al. [17] to conclude that the sesquiterpene
lactones bind with equal a⁄nity to E1Ca2, E1 and
E2. The observed decrease in a⁄nity for Ca2 is due
to a high equilibrium constant of 5.0U103 for
EA2 TG/E2.TG to give an overall binding constant
for E2+TGHEA2 TG of 4.0U10
10, where EA2 TG is
the stable isomer of E2TG [17]. It follows that in
the experiments reported here, addition of a molar
excess of TG to SR vesicles in the Ca2-limited
steady state would result in rapid inhibition (6 2 s)
of the pump with virtually all of enzyme sequestered
as the EA2 TG complex. Both proposed reaction
schemes predict that in the presence of excess TG
greater than 99% of the total enzyme will be in the
Ca2-free E2 form.
A reaction scheme for the Ca2-ATPase pump
cycle has been formulated by Inesi and De Meis
[36] that includes 12 intermediate states and their
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associated ¢rst- and second-order rate constants at
25‡C. It is assumed in the present study that
[Ca2]out is 100 nM, [Ca2]in is 10 WM, and [ATP],
[ADP] and [Pi] are 1.8, 0.2 and 0.2 mM, as a result of
10% hydrolysis of the initial 2 mM ATP. Steady-
state levels of all intermediate species were deter-
mined by numerical integration, and the results are
shown in Table 1. Total phosphorylated species is
0.27%, and total Ca2 bound species 0.93%. It is
possible that lumenal [Ca2]free is in excess of the
value, 10 WM, of the equilibrium value for calcium
oxalate precipitation. A simulation for intralumenal
[Ca2]free of 1 mM has also been calculated, in which
case total E-P and total Ca2-bound species would
be 0.75% and 1.64%, respectively.
Assuming that a major fraction of the Ca2-ATP-
ase at [Ca2]lim is in the Ca2-free form, and that
simulation predicts that TG will convert all inter-
mediates into a form that excludes Ca2 binding, it
can be assumed that the phenomenon of TG-induced
Ca2 release cannot be explained on the basis of the
reaction mechanisms quoted above.
Several properties of Ca2 release suggest that the
Ca2-ATPase is the target for TG related e¡ects.
Stoichiometry of TG/E of 2:1 is compatible. Stoichi-
ometry of Ca2 released varies between 0.25 and 1.0
Ca2/mol ATPase. Our preparation of SR vesicles is
enriched with cisternal SR, from which terminal re-
lease channels are excluded. Ruthenium red, which
blocks ryanodine sensitive Ca2 release channels, had
little e¡ect on the amount and kinetics of TG-in-
duced Ca2 release.
Inesi and De Meis [36] have characterised Ca2
£uxes across SR vesicles in the absence of oxalate,
where Ca2 uptake is inhibited by accumulation of
millimolar intravesicular Ca2. Under these condi-
tions the net £ux ceases due to inhibition of Ca2
release from E2-P.2Ca. Passive Ca2 e¥ux in this
steady state is equally divided into e¥ux through
the lipid bilayer, slippage of the Ca2 pump, and
via cycling of Ca2 bound E2HE1 forms in the ab-
sence of phosphorylation.
Reuptake of Ca2 following the release phase var-
ied. It was maximal immediately after ATP addition
and declined later until undetectable at 5 min delay.
It was also highly pH dependent, being absent at pH
6.0, and maximal at pH 8.0, where almost all of the
Ca2 released was taken up within 2 min (data not
shown). Reuptake was decreased, but not abolished
by TG in the 2^10 WM range, and was almost com-
Table 1
Simulation of steady-state concentrations of intermediate species of the Ca2-ATPase catalytic cycle in the Ca2-limited state
Intermediate [Ca2]in = 10 WM [Ca2]in = 1 mM
(M) (%) (M) (%)
E1 7.62 E-09 8.97 E-07
Ca.E1 3.80 E-09 4.39 E-09
Ca.E1* 1.56 E-09 1.80 E-09
Ca2.E1* 1.07 E-11 1.58 E-11
Ca2.E1*.ATP 7.44 E-10 1.32 E-09
(Ca)2.E1*VP.ADP 1.79 E-10 3.62 E-10
Ca2.E2*^P.ADP 1.72 E-10 3.93 E-10
Ca2.E2*^P 9.07 E-11 5.53 E-10
Ca.E2*^P 1.38 E-09 3.16 E-09
Ca.E2^P 1.38 E-09 1.73 E-09
E2^P 1.15 E-07 5.37 E-08
E2.Pi 1.15 E-07 5.31 E-08
Total intermediate species 1.000 E-06 (100) 1.000 E-06 (100)
Total E-P species 2.70 E-09 (0.04) 7.52 E-09 (0.75)
Total bound Ca2 9.27 E-09 (0.93) 1.64 E-08 (1.64)
Concentrations of reaction intermediates were simulated from a reaction scheme and rate constants according to Inesi and de Meis
[36], which were originally determined under conditions of T = 25‡C, 5 mM MgCl2, pH 7.0 and 80 mM KCl. Initial conditions were
set at ATP = 1.8 mM, ADP = 0.2 mM, Pi = 0.2 mM, [Ca2]free = 50 nM and [E]total = 1.0 WM. Simulation was carried out by numerical
integration, with a step interval of 0.1 ms, and total integration time of 2 s.
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pletely inhibited by 1 mM VO334 . Taken together
these ¢ndings suggest that Ca2 reuptake is due to
slow turnover of the Ca2 pump in the presence of
TG. The reason why reuptake is not seen with GTP
or AcP as substrates is not clear (Fig. 6). One possi-
bility is that it may be related to the speci¢city of the
‘regulatory’ nucleotide site that accelerates several of
the intermediary reactions involved in the formation
and hydrolysis of E2-P, and which have a high spe-
ci¢city for ATP.
The alternating access model for the E1HE2 iso-
merisation step initially was viewed as a pair of Ca2
sites that switched orientation and a⁄nity with phos-
phorylation and dephosphorylation of the ATPase
[37,38]. Positive cooperative binding to two sites
within a channel-like structure has been proposed,
based on the inhibition of release of the deeper site,
labelled with 45Ca2, by medium 40Ca2 [4,6,33,39].
Transfer of two Ca2 to lumenal sites on phosphor-
ylation is followed by dephosphorylation and rand-
omised release to the lumen [35,40]. Forge et al. [12]
and Duggleby et al. [41] have described biphasic re-
lease of Ca2 from lumenal sites at pH 8.0 and 5‡C,
suggesting that release of Ca2 from low-a⁄nity sites
is also sequential. A single channel-like mechanism
predicts that the deeper cytosolic site would be re-
leased to the lumen earlier than the more super¢cial
site. However, the rate of release of 45Ca2 was sim-
ilar when label was bound either to deep or super-
¢cial cytosolic sites. Together, these data show that
although both E1 and E2 sites bind and release se-
quentially, the two transported Ca2 ions are rand-
omised between these intermediate states.
Occluded cation species are believed to be a com-
mon feature of all P-type cation pumps [42]. The
occluded E-PG2Caf form, representing the intermedi-
ate state between E1-P.2Ca and E2-P.2Ca, is transi-
ent and has not been observed directly under steady-
state conditions, since E-P.2Ca is intrinsically unsta-
ble. It only deoccludes by a slow conformational
change or by reverse dephosphorylation by ADP. It
is, however, formed rapidly and is stable for hours
when a non-covalent ‘EP-like’ state is formed with
CrATP [43]. Chemical modi¢cation of the ATPase at
its active site also results in stabilising the occluded
Ca2 intermediate. McIntosh et al. have shown that
glutaraldehyde inhibits enzyme activity by forming
an intramolecular cross-link at the active site be-
tween Lys492 and Arg678, leading to a prolonged
phase of the occluded Ca2 species when phosphor-
ylated by acetyl phosphate [44]. In this case deocclu-
sion via the low-a⁄nity Ca2 sites to the lumen is
blocked. Instead, occluded Ca2 is released to the
cytoplasmic surface, through a pathway that uncou-
ples the transport cycle [45].
The fact that the stoichiometry of the TG-released
Ca2 fraction has a maximum of 3.0^4.0 nmol/mg
ATPase, equivalent to 0.75^1.0 mol/mol ATPase, is
perhaps the strongest evidence for an occluded spe-
cies EGCa2f, that accumulates during enzyme turn-
over, and which slowly decays during the Ca2-lim-
ited state. A species of tightly bound Ca2 has been
identi¢ed on the SR Ca2ATPase that is not re-
moved at lowered temperature with EGTA, but can
be released under conditions, including mild acid,
and EGTA at 37‡C, that uncouple transport from
ATPase activity [46]. Ca2, in addition to that bind-
ing to transport sites, has been shown to be necessary
for full activation of the Ca2-ATPase [47]. Prior
incubation with EGTA leads to inhibition of activity,
which is partially restored by preincubation with
Ca2. Plasma membrane Ca2-ATPase also contains
a species of Ca2 that is ¢rmly bound, not chased by
EGTA, and independent of the transport sites, that
has been suggested to play a structural role [48].
The present study has identi¢ed a species of Ca2
that can be released from the Ca2-ATPase by TG
under conditions that favour vacant cytoplasmic and
lumenal Ca2 binding sites. Simulation indicates that
unliganded E1 and E2 account for s 99% of the total
enzyme. One possibility is that in the presence of TG
the enzyme acts as an ionophore for Ca2, via cy-
cling of the non-phosphorylated forms E1 and E2.
Channel-like behaviour is unlike the ¢xed stoichiom-
etry of partial release of intravesicular contents of
calcium oxalate. Another more favoured hypothesis
is that during the Ca2limited state, when [Ca2]free
is less than 100 nM, occluded Ca2 persists and is
stabilised for lengthy periods of up to 1^2 h.
Possible models of active Ca2 transport are
shown in Scheme 1. The E1^E2 model, as originally
described, included a pair of sites with two major
conformational states with high and low a⁄nities,
controlled by gates, which allowed alternate access
to the two membrane surfaces, and shown in Scheme
1A. However, no single large conformational change
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has been found, rather a number of smaller confor-
mational changes have been followed by tryptophan
auto£uorescence on binding and release of ligands to
the Ca2-ATPase. Alternatively, there is evidence for
a four-site model.
Mezaros and Bak [7] showed that it is possible to
simultaneously bind Ca2 to E1 and occlude bound
Ca2. Jencks et al. [8] described how lumenal Ca2
inhibits phosphorylation from Pi due to coexistence
of both high-a⁄nity cytoplasmic and low-a⁄nity lu-
menal sites on the non-phosphorylated ATPase.
Canet et al. [12] also showed that although Ca2
release from cytoplasmic and lumenal sites are se-
quential, suggesting that they are bound in some
sort of channel, their transfer results in randomisa-
tion. Consequentially they have suggested that ligand
bonds are weakened in the occluded state to explain
this randomisation (Scheme 1B). The present study,
which demonstrates coexistence of the occluded state
as well as low and high-a⁄nity sites supports a
mechanism with randomisation in the occluded spe-
cies (Scheme 1C). This di¡ers from Scheme 1B in
that here randomisation involves the deeper site of
two each of the of the high- and low-a⁄nity sites,
whereas in mechanism C occluded sites exist inde-
pendently.
The standard E1^E2 reaction scheme includes two
Ca2 binding sites per ATPase at any one instant.
The present ¢ndings favour an occluded species in
addition to the four-site models. The experimental
system should provide opportunity to analyse oc-
cluded states, especially since the species is stable
for hours at room temperature.
According to the present in vitro analysis, interac-
tion of TG with SR or ER Ca2-ATPases, under
conditions that approximate those in relaxed muscle,
or in other tissues during the unstimulated state,
would release 4 nmol Ca2 per mg from sites on
the ATPase. Some idea of the magnitude from this
source can be calculated for cardiac muscle, where
the content of SR in intact muscle tissue has been
determined by Thapsigargin titration to be 8.0 mg/g
[49]. Assuming that cellular water is approximately
70% (v/w), this would lead to an increase in total
cytosolic Ca2, both free and bound, of 46 WM.
The amount of Ca2 released by direct interaction
of TG with SERCA’s needs to be considered when
analysing the e¡ects of this inhibitor on cellular Ca2
metabolism.
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